| Steven E Burgess, MD | |
|
214 E 23rd St, Cheyenne, WY 82001-3748 | |
| (307) 432-6629 | |
| (307) 432-6634 |
| Full Name | Steven E Burgess |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 16 Years |
| Location | 214 E 23rd St, Cheyenne, Wyoming |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891956371 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 11576A (Wyoming) | Secondary |
| 207Q00000X | Family Medicine | 11576A (Wyoming) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cheyenne Regional Medical Center | Cheyenne, WY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Memorial Hospital Of Laramie County | 1557357555 | 68 |
| Summit Hospitalist Group Llc | 8527445824 | 8 |
News Archive
Researchers have just established a structural basis for two spike glycoprotein epitopes of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that are restricted to human leukocyte antigen (HLA) A2 molecules. More specifically, they are involved in the presentation of antigenic peptides to specific T lymphocytes and recognized by public and private T cell receptors. The research is currently available on the bioRxiv* preprint server.
SurgiQuest, Inc., a leading provider of innovative access technologies for minimally invasive surgery (MIS), today announced that its AirSeal System recently received 510(k) Clearance from the FDA for Transanal Endoscopic Surgery (TES).
Many people may groan about losing an hour of sleep March 13, but there may be a more serious reason to be mindful of daylight saving time.
Recent research discoveries in the development of brain disorders could pave the way to new therapies for treating seizures, and even some children with autism, says a leading oncologist and researcher at the University of Alberta.
Today, at the 52nd annual New Clinical Drug Evaluation Unit (NCDEU) Conference in Arizona, Ian Cook, M.D., Professor of Psychiatry at the University of California, Los Angeles (UCLA) and a Senior Medical Advisor to NeuroSigma, Inc., presented the results from the first 6-subject cohort of a 10-subject Phase I open-label clinical trial studying the effects of external trigeminal nerve stimulation (eTNS) on Post-Traumatic Stress Disorder (PTSD) and depressive symptoms in Major Depressive Disorder (MDD) as an adjunct to pharmacotherapy.
› Verified 6 days ago
| Entity Name | Memorial Hospital Of Laramie County |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285621839 PECOS PAC ID: 1557357555 Enrollment ID: O20040423001172 |
News Archive
Researchers have just established a structural basis for two spike glycoprotein epitopes of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that are restricted to human leukocyte antigen (HLA) A2 molecules. More specifically, they are involved in the presentation of antigenic peptides to specific T lymphocytes and recognized by public and private T cell receptors. The research is currently available on the bioRxiv* preprint server.
SurgiQuest, Inc., a leading provider of innovative access technologies for minimally invasive surgery (MIS), today announced that its AirSeal System recently received 510(k) Clearance from the FDA for Transanal Endoscopic Surgery (TES).
Many people may groan about losing an hour of sleep March 13, but there may be a more serious reason to be mindful of daylight saving time.
Recent research discoveries in the development of brain disorders could pave the way to new therapies for treating seizures, and even some children with autism, says a leading oncologist and researcher at the University of Alberta.
Today, at the 52nd annual New Clinical Drug Evaluation Unit (NCDEU) Conference in Arizona, Ian Cook, M.D., Professor of Psychiatry at the University of California, Los Angeles (UCLA) and a Senior Medical Advisor to NeuroSigma, Inc., presented the results from the first 6-subject cohort of a 10-subject Phase I open-label clinical trial studying the effects of external trigeminal nerve stimulation (eTNS) on Post-Traumatic Stress Disorder (PTSD) and depressive symptoms in Major Depressive Disorder (MDD) as an adjunct to pharmacotherapy.
› Verified 6 days ago
| Entity Name | Summit Hospitalist Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356985600 PECOS PAC ID: 8527445824 Enrollment ID: O20220505002316 |
News Archive
Researchers have just established a structural basis for two spike glycoprotein epitopes of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that are restricted to human leukocyte antigen (HLA) A2 molecules. More specifically, they are involved in the presentation of antigenic peptides to specific T lymphocytes and recognized by public and private T cell receptors. The research is currently available on the bioRxiv* preprint server.
SurgiQuest, Inc., a leading provider of innovative access technologies for minimally invasive surgery (MIS), today announced that its AirSeal System recently received 510(k) Clearance from the FDA for Transanal Endoscopic Surgery (TES).
Many people may groan about losing an hour of sleep March 13, but there may be a more serious reason to be mindful of daylight saving time.
Recent research discoveries in the development of brain disorders could pave the way to new therapies for treating seizures, and even some children with autism, says a leading oncologist and researcher at the University of Alberta.
Today, at the 52nd annual New Clinical Drug Evaluation Unit (NCDEU) Conference in Arizona, Ian Cook, M.D., Professor of Psychiatry at the University of California, Los Angeles (UCLA) and a Senior Medical Advisor to NeuroSigma, Inc., presented the results from the first 6-subject cohort of a 10-subject Phase I open-label clinical trial studying the effects of external trigeminal nerve stimulation (eTNS) on Post-Traumatic Stress Disorder (PTSD) and depressive symptoms in Major Depressive Disorder (MDD) as an adjunct to pharmacotherapy.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Steven E Burgess, MD Po Box 20970, Cheyenne, WY 82003-7020 Ph: (307) 432-6629 | Steven E Burgess, MD 214 E 23rd St, Cheyenne, WY 82001-3748 Ph: (307) 432-6629 |
News Archive
Researchers have just established a structural basis for two spike glycoprotein epitopes of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that are restricted to human leukocyte antigen (HLA) A2 molecules. More specifically, they are involved in the presentation of antigenic peptides to specific T lymphocytes and recognized by public and private T cell receptors. The research is currently available on the bioRxiv* preprint server.
SurgiQuest, Inc., a leading provider of innovative access technologies for minimally invasive surgery (MIS), today announced that its AirSeal System recently received 510(k) Clearance from the FDA for Transanal Endoscopic Surgery (TES).
Many people may groan about losing an hour of sleep March 13, but there may be a more serious reason to be mindful of daylight saving time.
Recent research discoveries in the development of brain disorders could pave the way to new therapies for treating seizures, and even some children with autism, says a leading oncologist and researcher at the University of Alberta.
Today, at the 52nd annual New Clinical Drug Evaluation Unit (NCDEU) Conference in Arizona, Ian Cook, M.D., Professor of Psychiatry at the University of California, Los Angeles (UCLA) and a Senior Medical Advisor to NeuroSigma, Inc., presented the results from the first 6-subject cohort of a 10-subject Phase I open-label clinical trial studying the effects of external trigeminal nerve stimulation (eTNS) on Post-Traumatic Stress Disorder (PTSD) and depressive symptoms in Major Depressive Disorder (MDD) as an adjunct to pharmacotherapy.
› Verified 6 days ago
Dr. Kristine K Van Kirk, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 6015 Sycamore Rd, Cheyenne, WY 82009 Phone: 307-823-2968 | |
Dr. Christian Alexander Flanders, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 820 E 17th St, Cheyenne, WY 82001 Phone: 307-632-2434 Fax: 307-634-3510 | |
Dr. Bradley Mohar, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 214 E 23rd St, Cheyenne, WY 82001 Phone: 307-634-2273 | |
Dr. Douglas W Edgren, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1331 Prairie Ave Ste 1, Cheyenne, WY 82009 Phone: 307-632-0728 | |
Zachary Dale Herman, Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 820 E 17th St, Cheyenne, WY 82001 Phone: 307-632-2434 Fax: 307-635-3510 | |
Margaret Ann Lembitz, NP Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3229 E Pershing Blvd, Cheyenne, WY 82001 Phone: 307-363-2054 Fax: 307-227-6817 | |
Benjamin Leishman, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 820 E 17th St, Cheyenne, WY 82001 Phone: 307-632-2434 |